Press Releases

/Press Releases

Oramed Appoints Dr. Arie Mayer to Board of Directors

Dr. Mayer is the current Managing Director and Chairman of the Board of Merck Life Science Israel NEW YORK, Dec. 5, 2019 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, [...]

2019-12-05T09:12:00+00:00 Categories: Press Releases|Tags: |

Oramed to Present a Scientific Poster at International Diabetes Federation Congress

NEW YORK, December 2, 2019 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today it will present a scientific poster at the 2019 International Diabetes Federation (IDF) Congress in Busan, South [...]

2019-12-02T08:25:00+00:00 Categories: Press Releases|Tags: |

Oramed Patent Granted in Japan for Protease Inhibitor, a Key Component of Platform Technology

NEW YORK, Nov. 21, 2019 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that its Japanese patent for the technology "Protease Inhibitor – Containing Compositions, Compositions Comprising Same, and [...]

2019-11-21T08:27:00+00:00 Categories: Press Releases|Tags: |

Oramed Pharmaceuticals to Discuss Positive Phase IIb Data at Investor Event and Conference Call on Monday, November 18th

NEW YORK, Nov. 14, 2019 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, will hold an investor event and conference call to review the positive results from the initial cohort of the Phase [...]

2019-11-14T07:28:00+00:00 Categories: Press Releases|Tags: |

Oramed to Present at Ladenburg Thalmann 2019 Healthcare Conference

NEW YORK, Sept. 18, 2019 /PRNewswire/ --  Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that the company's Chief Executive Officer, Nadav Kidron, will  present and participate in one-on-one meetings [...]

2019-09-18T08:38:00+00:00 Categories: Press Releases|Tags: |

Oramed to Present at Three Upcoming Conferences

NEW YORK, Sept. 3, 2019 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that the company will present at three conferences in New York in the first half of September [...]

2019-09-03T08:25:00+00:00 Categories: Press Releases|Tags: |

Oramed to Present at World Diabetes Congress

NEW YORK, July 10, 2019 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that Dr. Miriam Kidron, Chief Scientific Officer of Oramed, will deliver two presentations at the World Diabetes [...]

2019-07-10T08:40:00+00:00 Categories: Press Releases|Tags: |